Ingestion of arsenic-contaminated drinking water is associated with an increased risk of several cancers, including skin and bladder malignancies; but it is not yet clear whether such adverse effects are present at levels to which the U.S. population is exposed. In New Hampshire, detectable levels of arsenic have been reported in drinking water supplies throughout the state. Therefore, we have begun a population-based epidemiologic case-control study in which residents of New Hampshire diagnosed with primary squamous cell (n=900) and basal cell (n= 1200) skin cancers are being selected from a special statewide skin cancer incidence survey; patients diagnosed with primary bladder cancers (n=450) are being identified through the New Hampshire State Cancer Registry. Exposure histories of these patients will be compared to a control group of individuals randomly selected from population lists (n= 1200). Along with a detailed personal interview, arsenic and other trace elements are being measured in toenail clipping samples using instrumental neutron activation analysis. Household water samples are being tested on selected participants using a hydride generation technique with high-resolution inductively coupled plasma mass spectrometry. In the first 793 households tested, arsenic concentrations ranged from undetectable (0.01 pg/l) to 180 pg/I. Over 10% of the private wells contained levels above 10 pg/i and 2.5% were above 50 pg/i. Based on our projected sample size, we expect at least 80% power to detect a 2-fold risk of basal cell or squamous cell skin cancer or bladder cancer among individuals with the highest 5% toenail concentrations of arsenic. Environ
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Address correspondence to M.R. Karagas preservatives, feed additives, and semiconductor applications (e.g., gallium arsenide). Patients were treated with arsenic-containing drugs such as potassium arsenite (e.g., Fowler solution) for benign skin conditions in the 19th and early 20th century, but arsenic is now rarely used medicinally (1) .
In high concentrations (e.g., > 2000 pg/kg/day), arsenic is toxic to humans, and among the reported long-term health effects associated with nonfatal doses are vascular diseases, diabetes, and cancers-specifically cancers of the skin (basal cell and squamous cell), lung, bladder, kidney, and liver. These observations have been made among individuals exposed to arsenic occupationally or through drinking water contamination or pharmacologic uses (2) . In humans, organic arsenic compounds (e.g., arsenobetaine, found in seafood) are not as toxic as inorganic arsenic. The carcinogenic effects of organic arsenic are uncertain, although there was no apparent increase in skin cancers among patients treated with organic arsenics for syphillis (3) .
Estimates of the dose-response relationship between drinking water arsenic exposure and cancer have been made from studies conducted in a region of Taiwan that had artesian well water highly contaminated with arsenic. In a well-known household prevalence survey of skin cancer (4) published about 30 years ago, villages with median water arsenic concentrations of 170, 470, and 800 pg/l had skin cancer prevalence rates of 26, 101, and 214 per 1000 persons, respectively (4). More recently, Brown and colleagues (5) performed a reanalysis of these data using a multistaged model. A model that included both a linear and quadratic term in dose improved the fit only slightly; thus there was no definitive conclusion regarding the actual shape of the dose-response curve. Among the limitations of the Taiwanese study are that data are provided for the median concentration for all wells in a village, and in some villages concentrations varied considerably, i.e., from nearly 0 to over 1200 pg/I. Of some reassurance is that data from a study conducted in Mexico (with similar limitations) (5) also appeared to fit the model derived from Taiwan data. Smith and colleagues (6) 6 years apart, arsenic was among the most highly correlated of the elements they analyzed (a correlation of greater than 0.5) (17) . Measurement of arsenic directly in water samples is another alternative. However, at the time our study began, we were uncertain whether water concentrations varied appreciability over time, i.e., seasonally or from year to year. Moreover, water is only one potential source of exposure. In our small pilot study, the overall correlation between water and toenail concentrations of arsenic was 0.67 (18) ; however, half of the samples were drawn from regions of New Hampshire known to have relatively high water levels of arsenic. A significant correlation between water concentrations and both hair and toenail levels of arsenic was also recently reported by Chiou and colleagues (19) . In this study, genetic polymorphism in the GSTMJ or GSTTI loci, which had an effect on the metabolic forms of arsenic in urine, did not (21) (e.g., selenium, zinc).
Water samples are being tested using a hydride-generation technique with a highresolution inductively coupled plasma mass spectrometer (HR-ICP-MS) (22) . Using this approach, a quantitative estimate of arsenic is obtained for 99 % of the water samples. The instrument is a Finnigan MAT Element (Bremen, Germany) HR-ICP-MS. Although lower detection limits are possible, the quantification limit for samples was set to 0.01 pg/l (0.001 pg/l for blanks) to avoid excessive washout times. Levels below 1 pg/l are not suspected of posing a health risk; therefore, from a practical perspective it may not be necessary to measure arsenic at such trace levels. However, we also are interested in the correlation between toenail and water concentrations and arsenic is detectable in all nail samples. Likewise, we are examining the geographic distribution of arsenic in water throughout the state.
Accurate quantification of arsenic necessitates strict precautions against contamination. All sample preparations and analyses are carried out in a trace-metal clean HEPA-filtered-air environment. Commercially washed (mineral-free) highdensity polyethylene bottles meet U.S. EPA standards for water collection (I-Chem, Newcastle, DE); however, we are unaware of any published data on the performance of these bottles for arsenic determination. Therefore, we prepared acid-washed polyethylene bottles in our class 100 clean room and initially used these on all households with private wells and on a random sample of those with public water. Commercial bottles were used for the rest of the households because we expected a smaller fraction of public water would have detectable arsenic. Powderless latex gloves are worn during the collection and bottles are kept in a washed sealed plastic bag. Samples of cold water are taken after running the tap for at least 1 min to avoid metal precipitation in the pipes. Samples are immediately placed back into the sealed bag. Duplicate samples are drawn on 10% of the households (every 10th interview) throughout the study, and field blanks are performed quarterly by each interviewer. To compare the performance of the two bottle-washing methods, we tested water from a sample of households using both types. All bottles are labeled with identification numbers that do not reveal the case-control status of the study participants or whether the sample was a replicate from the same household. In addition to these quality control samples, analytical blanks and potential instrumental drifts are carefully monitored, and instrument standardization and reproducibility is performed with certified standard reference materials.
Water Arsenic Results
In the 793 households tested to date (Table 1) , 41% reported using a private well or spring (serving 15 or fewer households or less than 25 individuals). Arsenic concentrations range from undetectable (< 0.01 pg/l) to 180 pg/I. Over 25% of the private wells contained more than 2 pg/l of arsenic, over 10% were above 10 pg/I, and 2.5% were over 50 pg/l. In a preliminary analysis of the population controls, we found that participants residing in the three major cities of New Hampshire (Concord, Manchester, or Nashua) had lower water arsenic on average (data not shown). However, participants from these areas comprise only about 20% of our sample.
A preliminary analysis was performed on the replicate samples tested thus far. Simple random effects models were used to calculate intraclass correlations for the log transformed arsenic measurements (23) . The intraclass correlation coefficient for replicate samples was 0.98 and did not appear to differ by bottle type (i.e., laboratory cleaned or commercially cleaned containers). Given this high correlation, we concluded that the bottle types yield highly comparable and reliable results in our laboratory. are also using a biologic measure of arsenic exposure (toenail clippings) that, based on our pilot work, is highly correlated with water concentrations. We plan to further evaluate the relation between water and toenail levels in our larger study and to assess the contribution of other sources of arsenic exposure such as tobacco smoking and occupation on toenail levels. Our analysis of household water samples will also help clarify the sources and mechanisms of arsenic presence in the drinking water supply. As part of the study, we are establishing a specimen bank of blood and tumor samples that can be used in future studies to evaluate potential susceptibility genes or tumor markers of arsenic exposure. Based on the projected sample size, we expect that our study will help fill important gaps in our knowledge regarding the relation between arsenic exposure and skin and bladder cancer risk in the United States.
